Current Neuro-Oncology

Volume 15 Number 12
December 2013

Home > Publications > Current Neuro-Oncology > Volume 15, Year 2013 > Number 12, December


Da Fonseca CO, Teixeira RM, Silva JC, De Saldanha DA Gama Fischer J, Meirelles OC, Landeiro JA, Quirico-Santos T.
Long-term outcome in patients with recurrent malignant glioma treated with Perillyl alcohol inhalation.
Anticancer Res. 2013 Dec;33(12):5625-31
. PMID: 24324108. Retrospective analysis.

Inoue A, Harada H, Miura N, Nishikawa M, Fukumoto T, Kohno S, Ohue S, Tanji N, Ohnishi T.
A case of neurosurgery for meningioma in a chronic hemodialysis patient: perioperative management of chronic hemodialysis patients requiring neurosurgery.
No Shinkei Geka. 2013 Dec;41(12):1087-92. doi: 10.11477/mf.1436102134
🡥. PMID: 24317885🡥. Case report; 🡥

Harris D, Barts A, Connors J, Dahl M, Elliott T, Kong J, Keane T, Thompson D, Stafford S, Ur E, Sirrs S.
Glucocorticoid-induced hyperglycemia is prevalent and unpredictable for patients undergoing cancer therapy: an observational cohort study.
Curr Oncol. 2013 Dec 1;20(6):e532-8. doi: 10.3747/co.20.1499
🡥. PMID: 24311953🡥. Observational study. 🡥

Soffietti R, Trevisan E, Bertero L, Cassoni P, Morra I, Fabrini MG, Pasqualetti F, Lolli I, Castiglione A, Ciccone G, Rudà R.
Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology).
J Neurooncol. 2013 Dec 1. 2014;116(3):533-41. doi: 10.1007/s11060-013-1317-x
. PMID: 24293233. Phase 2 trial.

Bandopadhayay P, Bergthold G, Nguyen B, Schubert S, Gholamin S, Tang Y, Bolin S, Schumacher SE, Zeid R, Masoud S, Yu F, Vue N, Gibson WJ, Paolella BR, Mitra SS, Cheshier SH, Qi J, Liu KW, Wechsler-Reya R, Weiss WA, Swartling FJ, Kieran MW, Bradner JE, Beroukhim R, Cho YJ.
BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma.
Clin Cancer Res. 2013 Dec 2. 2014;20(4):912-25. doi: 10.1158/1078-0432.CCR-13-2281
🡥. PMID: 24297863🡥. Laboratory investigation. 🡥

Buglione M, Pedretti S, Gipponi S, Todeschini A, Pegurri L, Costa L, Donadoni L, Grisanti S, Fontanella M, Liserre R, Facchetti F, Padovani A, Magrini SM.
Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis.
Radiol Med. 2013 Dec 3. doi:10.1007/s11547-013-0347-y
🡥. PMID: 24297587🡥. Retrospective analysis. 🡥

Saratsis AM, Kambhampati M, Snyder K, Yadavilli S, Devaney JM, Harmon B, Hall J, Raabe EH, An P, Weingart M, Rood BR, Magge SN, Macdonald TJ, Packer RJ, Nazarian J.
Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes.
Acta Neuropathol. 2013 Dec 3. 2014;127(6):881-95. doi: 10.1007/s00401-013-1218-2
🡥. PMID: 24297113🡥. Laboratory investigation. 🡥


Chuang NA, Yoon JM, Newbury RO, Crawford JR.
Glioblastoma Multiforme Arising From Dysembryoplastic Neuroepithelial Tumor in a Child in the Absence of Therapy.
J Pediatr Hematol Oncol. 2013 Dec 4. 2014;36(8):e536-9. doi: 10.1097/MPH.0000000000000063
. PMID: 24309599. Case report.

Fouse SD, Nakamura JL, James CD, Chang S, Costello JF.
Response of primary glioblastoma cells to therapy is patient specific and independent of cancer stem cell phenotype.
Neuro Oncol. 2013 Dec 4. 2014;16(3):361-71. doi: 10.1093/neuonc/not223
. PMID: 24311636. Laboratory investigation.

Gill SK, Wilson M, Davies NP, MacPherson L, English M, Arvanitis TN, Peet AC.
Diagnosing relapse in children's brain tumors using metabolite profiles.
Neuro Oncol. 2013 Dec 4. 2014;16(1):156-64. doi: 10.1093/neuonc/not143
🡥. PMID: 24305716🡥. Retrospective analysis. 🡥

Gururangan S, Fangusaro J, Poussaint TY, McLendon RE, Onar-Thomas A, Wu S, Packer RJ, Banerjee A, Gilbertson RJ, Fahey F, Vajapeyam S, Jakacki R, Gajjar A, Goldman S, Pollack IF, Friedman HS, Boyett JM, Fouladi M, Kun LE.
Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium study.
Neuro Oncol. 2013 Dec 4. 2014;16(2):310-7. doi: 10.1093/neuonc/not154
🡥. PMID: 24311632🡥. Phase 2 trial. 🡥

Hartman LL, Crawford JR, Makale MT, Milburn M, Joshi S, Salazar AM, Hasenauer B, Vandenberg SR, Macdonald TJ, Durden DL.
Pediatric Phase II Trials of Poly-ICLC in the Management of Newly Diagnosed and Recurrent Brain Tumors.
J Pediatr Hematol Oncol. 2013 Dec 4. 2014;36(6):451-7. doi: 10.1097/MPH.0000000000000047
🡥. PMID: 24309609🡥. Phase 2 trial. 🡥

Herrmann K, Czernin J, Cloughesy T, Lai A, Pomykala KL, Benz MR, Buck AK, Phelps ME, Chen W.
Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients.
Neuro Oncol. 2013 Dec 4. 2014;16(4):603-9. doi: 10.1093/neuonc/not166
. PMID: 24305722 Retrospective analysis.

Hutterer M, Nowosielski M, Haybaeck J, Embacher S, Stockhammer F, Gotwald T, Holzner B, Capper D, Preusser M, Marosi C, Oberndorfer S, Moik M, Buchroithner J, Seiz M, Tuettenberg J, Herrlinger U, Wick A, Vajkoczy P, Stockhammer G.
A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07).
Neuro Oncol. 2013 Dec 4. 2014;16(1):92-102. doi: 10.1093/neuonc/not161
. PMID: 24311637. Ptase 2 trial.

Piscione PJ, Bouffet E, Mabbott DJ, Shams I, Kulkarni AV.
Physical functioning in pediatric survivors of childhood posterior fossa brain tumors.
Neuro Oncol. 2013 Dec 4. 2014;16(1):147-55. doi: 10.1093/neuonc/not138
🡥. PMID: 24305707🡥. Retrospective analysis. 🡥

Tran AN, Lai A, Li S, Pope WB, Teixeira S, Harris RJ, Woodworth DC, Nghiemphu PL, Cloughesy TF, Ellingson BM.
Increased sensitivity to radiochemotherapy in IDH1 mutant glioblastoma as demonstrated by serial quantitative MR volumetry.
Neuro Oncol. 2013 Dec 4. 2014;16(3):414-20. doi: 10.1093/neuonc/not198
. PMID: 24305712. Retrospective analysis.

Weller M, Soffietti R, Brada M.
The legend of cytomegalovirus and glioblastoma lives on.
Neuro Oncol. 2013 Dec 4. 2014;16(1):166. doi: 10.1093/neuonc/not204
. PMID: 24311642. Comment.

Krause M, Baumann M.
Reduced acute toxicity for adults with medulloblastoma treated with proton beam craniospinal irradiation.
Strahlenther Onkol. 2013 Dec 5. 2014;190(1):111-2. doi: 10.1007/s00066-013-0492-1
🡥. PMID: 24306067🡥. Retrospective analysis. 🡥

Pinho MC, Polaskova P, Kalpathy-Cramer J, Jennings D, Emblem KE, Jain RK, Rosen BR, Wen PY, Sorensen AG, Batchelor TT, Gerstner ER.
Low incidence of pseudoprogression by imaging in newly diagnosed glioblastoma patients treated with cediranib in combination with chemoradiation.
Oncologist. 2013 Dec 5. 2014;19(1):75-81. doi: 10.1634/theoncologist.2013-0101
. PMID: 24309981. Phase 1-2 trial.

Reynés G, Balañá C, Gallego O, Iglesias L, Pérez P, García JL.
A phase I study of irinotecan in combination with metronomic temozolomide in patients with recurrent glioblastoma.
Anticancer Drugs. 2013 Dec 5. 2014;25(6):717-22. doi: 10.1097/CAD.0000000000000059
. PMID: 24322542. Phase 1 trial.

Della Puppa A, Gioffrè G, Gardiman MP, Frasson C, Cecchin D, Scienza R, Persano L.
Intra-operative 5-aminolevulinic acid (ALA)-induced fluorescence of medulloblastoma: phenotypic variability and CD133(+) expression according to different fluorescence patterns.
Neurol Sci. 2013 Dec 7. 2014;35(1):99-102. doi: 10.1007/s10072-013-1597-0
🡥. PMID: 24318560🡥. Case report. 🡥

Brodin NP, Munck Af Rosenschöld P, Blomstrand M, Kiil-Berthlesen A, Hollensen C, Vogelius IR, Lannering B, Bentzen SM, Björk-Eriksson T.
Hippocampal sparing radiotherapy for pediatric medulloblastoma: impact of treatment margins and treatment technique.
Neuro Oncol. 2013 Dec 9. 2014;16(4):594-602. doi: 10.1093/neuonc/not225
🡥. PMID: 24327585🡥. Clinical trial. 🡥

Grill J, Dufour C.
Neuro-oncology: Stability of medulloblastoma subgroups at tumour recurrence.
Nat Rev Neurol
. 2013 Dec 10. 2014;10(1):5-6. doi: 10.1038/nrneurol.2013.256🡥. PMID: 24323052🡥. Comment. 🡥
Refers to: Ramaswamy V, et al. Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis.
Lancet Oncol. 2013 Oct 17. 2013;14(12):1200-7. doi: 10.1016/S1470-2045(13)70449-2🡥. PMID: 24140199🡥. Retrospective analysis. 🡥
Lancet Oncol. 2014 Mar 31. 2014;15(4):e154. doi: 10.1016/S1470-2045(14)70150-0🡥. Correction. 🡥

Shen W, Hu JA, Zheng JS.
Mechanism of temozolomide-induced antitumour effects on glioma cells.
J Int Med Res. 2013 Dec 10. 2014;42(1):164-72. doi: 10.1177/0300060513501753
. PMID: 24326954. Laboratory investigation.

Patanè M, Porrati P, Bottega E, Morosini S, Cantini G, Girgenti V, Rizzo A, Eoli M, Pollo B, Sciacca FL, Pellegatta S, Finocchiaro G.
Frequency of NFKBIA deletions is low in glioblastomas and skewed in glioblastoma neurospheres.
Mol Cancer. 2013 Dec 11;12:160. doi: 10.1186/1476-4598-12-160
. PMID: 24330732. Laboratory investigation.

Greenop KR, Peters S, Fritschi L, Glass DC, Ashton LJ, Bailey HD, Scott RJ, Daubenton J, de Klerk NH, Armstrong BK, Milne E.
Exposure to household painting and floor treatments, and parental occupational paint exposure and risk of childhood brain tumors: results from an Australian case-control study.
Cancer Causes Control. 2013 Dec 12. 2014;25(3):283-91. doi: 10.1007/s10552-013-0330-x
🡥. PMID: 24337771🡥. Case-control study 🡥

Johnson BE, Mazor T, Hong C, Barnes M, Aihara K, McLean CY, Fouse SD, Yamamoto S, Ueda H, Tatsuno K, Asthana S, Jalbert LE, Nelson SJ, Bollen AW, Gustafson WC, Charron E, Weiss WA, Smirnov IV, Song JS, Olshen AB, Cha S, Zhao Y, Moore RA, Mungall AJ, Jones SJM, Hirst M, Marra MA, Saito N, Aburatani H, Mukasa A, Berger MS, Chang SM, Taylor BS, Costello JF.
Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma.
Science. 2013 Dec 12. 2014;343(6167):189-193. doi: 10.1126/science.1239947. PMID: 24336570. Laboratory investigation.

Strother DR, Lafay-Cousin L, Boyett JM, Burger P, Aronin P, Constine L, Duffner P, Kocak M, Kun LE, Horowitz ME, Gajjar A.
Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34.
Neuro Oncol. 2013 Dec 12. 2014;16(3):457-65. doi: 10.1093/neuonc/not163
🡥. PMID: 24335695🡥. Randomized. 🡥

Tandon N, Esquenazi Y.
Resection strategies in tumoral epilepsy: is a lesionectomy enough?
Epilepsia. 2013 Dec 12. 2013;54 Suppl 9:72-8. doi: 10.1111/epi.12448
🡥. PMID: 24328877🡥. Retrospective analysis. 🡥


Caignard A, Faguer R, Mercier P, Menei P, Milea D.
Optic nerve and visual pathways primary glioblastoma treated with radiotherapy and temozolomide chemotherapy.
Eur J Ophthalmol. 2013 Dec 13. 2014;24(4):637-40. doi: 10.5301/ejo.5000416
. PMID: 24366773. Case report.

Yamashita Y, Ito Y, Isomura H, Takemura N, Okamoto A, Motomura K, Tsujiuchi T, Natsume A, Wakabayashi T, Toyokuni S, Tsurumi T.
Lack of presence of the human cytomegalovirus in human glioblastoma.
Mod Pathol. 2013 Dec 13. 2014;27(7):922-9. doi: 10.1038/modpathol.2013.219
. PMID: 24336154. Laboratory investigation.

Wick W, Wick A, Platten M.
Challenging cytomegalovirus data in glioblastoma.
Neuro Oncol. 2013 Dec 18. 2014;16(1):165. doi: 10.1093/neuonc/not212
. PMID: 24353326. Comment.
Stragliotto G, et al.
Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study.
Int J Cancer. 2013 Mar 13. 2013;133(5):1204-13. doi: 10.1002/ijc.28111
. PMID: 23404447. Phase 1-2 trial.
Söderberg-Nauclér C, et al.
Survival in patients with glioblastoma receiving valganciclovir.
N Engl J Med. 2013 Sep 5;369(10):985-6. doi: 10.1056/NEJMc1302145
. PMID: 24004141. Retrospective analysis.


Fernandez-Vega I, Quirk J, Norwood FL, Sibtain NA, Laxton R, Bodi I.
Gliomatosis cerebri type 1 with extensive involvement of the spinal cord and BRAF V600E mutation.
Pathol Oncol Res. 2013 Dec 19. 2014;20(1):215-20. doi: 10.1007/s12253-013-9732-z
. PMID: 24353007. Case report.

Gallego O, Cuatrecasas M, Benavides M, Segura PP, Berrocal A, Erill N, Colomer A, Quintana MJ, Balaña C, Gil M, Gallardo A, Murata P, Barnadas A.
Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry.
J Neurooncol. 2013 Dec 19. 2014;116(2):413-9. doi: 10.1007/s11060-013-1316-y
. PMID: 24352766. Prospective study.
J Neurooncol. 2014 Oct 28. 2014;120(3):667. doi:
10.1007/s11060-014-1643-7 Correction.